home / stock / ci / ci news


CI News and Press, Cigna Corporation From 05/02/24

Stock Information

Company Name: Cigna Corporation
Stock Symbol: CI
Market: NYSE
Website: cigna.com

Menu

CI CI Quote CI Short CI News CI Articles CI Message Board
Get CI Alerts

News, Short Squeeze, Breakout and More Instantly...

CI - Expected US Company Earnings on Thursday, May 2nd, 2024

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

CI - Cigna Non-GAAP EPS of $6.47 beats by $0.25, revenue of $57.3B beats by $670M

2024-05-02 06:05:21 ET More on Cigna Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018 The Cigna Group (CI) Barclays 26th Annual Global Healthcare Conference (Transcript) Cign...

CI - The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook

The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook PR Newswire Total revenues for the first quarter 2024 were $57.3 billion Shareholders' net loss for the first quarter 2024 was $0.3 billion , or $0.97 per share Adjuste...

CI - CVS Health hits 52-week low as Leerink downgrades after Q1 miss

2024-05-01 13:03:51 ET More on CVS Health CVS Health Corporation (CVS) Q1 2024 Earnings Call Transcript CVS Health Corporation 2024 Q1 - Results - Earnings Call Presentation CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot Biggest stock mov...

CI - Cigna Q1 2024 Earnings Preview

2024-05-01 11:29:36 ET More on Cigna Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018 The Cigna Group (CI) Barclays 26th Annual Global Healthcare Conference (Transcript) Cign...

CI - CVS Health drops as medical cost trends prompt guidance cut

2024-05-01 07:17:39 ET More on CVS Health CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot CVS Health: Seizing Opportunity Amid Recent Declines CVS Health: Good Management Is Keeping Their Promises CVS Health Non-GAAP EPS of $1.31 misses by...

CI - Alvotech to produce Humira biosimilar for Cigna's Quallent

2024-04-30 11:56:42 ET More on Alvotech Alvotech: Consider Buying As Positive Q1 Earnings Release Likely Alvotech (ALVO) Q4 2023 Earnings Call Transcript Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S. FDA approves Alvotech bios...

CI - Top 50 stocks with the highest sensitivity to interest rates changes - GS

2024-04-29 12:38:00 ET More on United States 10-Year Bond Yield: Wall Street Lunch: Bond Bulls In Hibernation Dollar Consolidates But Adjustment Is Not Over Wall Street Lunch: So Long Summer Of Rate Cuts Société Générale spotlights key tec...

CI - Earnings week ahead: Amazon, Apple, Pfizer, AMD, Coca-Cola, Starbucks and more

2024-04-28 08:00:00 ET As the calendar flips from April to May, the upcoming week is set to bring a flurry of earnings reports from some of the world's most prominent companies. At the top of the list, updates are anticipated from tech giants Amazon ( NASDAQ: AMZN ) and Apple ( NA...

CI - AbbVie stock slides 6% amid concerns about falling Humira sales

2024-04-26 14:09:10 ET More on AbbVie AbbVie Inc. (ABBV) Q1 2024 Earnings Call Transcript AbbVie's Q1: Positive Surprise AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment AbbVie Q1 report beats Street despite plunging Humira sales ...

Previous 10 Next 10